Event Information

Organiser：
Service Centre in Malaysia, Guangzhou Fuda Cancer Hospital, Affiliated to Jinan University

Event topic：
Living with Cancer
Fuda Cancer Treatment Consultation
Highlight：
1.Face-to-face Consultation with Chinese Clinical Oncologist for Tailor-made treatment plan
2.Knowledge of Internationally Advanced Treatment Technology
3.Knowledge of Featured Treatments in Fuda
4.Free Booklet of Cancer Education

Expert introduction

Dr. Leng Yin, M.D., PhD

Associate Chief Physician, Senior Clinical Oncologist of Fuda Cancer Hospital
Doctor of Medicine, Jinan University, China
Member of Chinese Anti-Cancer Association
Committee Member of Gastroenterology Branch of Guangdong Medical Association, China

Dr. Leng mainly specializes in clinical works and teaching of abdominal tumor surgery. He is good at the prevention, diagnosis and comprehensive treatment of tumors in liver, gallbladder, stomach, pancreas, intestinal tracts and breasts. He is involved in many researches on anti-tumor angiogenesis organized by National Natural Science Foundation of China and clinical trial research of immunotherapy for advanced cancer. In 2014, he was invited to Bumrungrad International Hospital and Royal Siriraj Hospital in Bangkok, Thailand for exchanging ideas on cancer prevention and treatment. At the same time, he was also invited to give a lecture on a new anti-cancer idea – “live with cancer” in National Broadcasting Services of Thailand (NBT). He advocates cancer treatment concepts – “alleviate patient’s pain, provide psychological counseling, improve their life quality and prolong life span”.

Chen Zhixian, Attending Physician

Senior Clinical Oncologist of Fuda Cancer Hospital
Member of Chinese Anti-cancer Association
Member of Multi-disciplinary Comprehensive Diagnosis and Treatment Committee of Guangdong Medical Society

Engaged in clinical work for more than ten years, Dr. Chen has published many signed papers and reviews, and has rich clinical experience in precise tumor treatment and immunotherapy, especially of liver cancer, gallbladder cancer, colon cancer, gastric cancer, etc. with unique insights. He is good at the diagnosis and treatment of complicated diseases, and has gained some accomplishments on minimally invasive tumor ablation therapies, such as brachytherapy, argon-helium cryosurgical ablation, microwave ablation, radiofrequency ablation and nano-knife ablation.

Anti-cancer stories in Fuda

• Gurlin, Danish, advanced pancreatic cancer, surviving for 11 years
• Singaporean, 85, advanced prostate cancer, surviving for 9 years
• Tan Youhao, Chinese, advanced liver cancer, surviving for 16 years
• Ms Luo, from Hong Kong, advanced breast cancer, surviving for 10 years

Anti-cancer treatment

Routine therapies

Surgery, radiotherapy, chemotherapy, targeted therapy, radiofrequency ablation, chemical ablation, radioactive stent, traditional Chinese medicine, China medicine, percutaneous ethanol injection, anti-angiogenesis

Distinctive therapies

Irreversible electroporation (Nano-knife), cryosurgery therapy, vascular interventional therapy, microsphere interventional therapy, brachytherapy, photodynamic therapy, combined immunotherapy, microwave ablation, microwave hyperthermia treatment, ozone therapy

Trust from patients in 100 countries and regions around the world

*Patients mainly come from

Since its establishment, FUDA has already treated patients from over 100 countries, including over 10,000 Southeast Asian patients.FUDA is deeply trusted by its patients.

FUDA Introduction

Fuda Cancer Hospital is considered one of good cancer hospitals in China by many patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, FUDA operates with international standards and was selected as the National Key Clinical Specialty (Oncology) Hospital in 2010. Moreover, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. As an international cancer hospital, Fuda adopts unique anti-cancer concept (to prolong patients’ quality life) and the latest international minimally invasive therapies, which benefited cancer patients from over 100 countries around the world.

Review of academic events

On Dec. 16, 2018, Prof. Xu Kecheng (Honorary Chief President of Fuda Cancer Hospital), Prof. Niu Lizhi (Vice President of Fuda Cancer Hospital) and Prof. Mu Feng (Vice President of Fuda Cancer Hospital) were invited to attend the 5^th Academy Conference for Asian Society of Cryosurgery (ASC) in Malaysia.

Prof. Niu Lizhi (Vice President of Fuda Cancer Hospital; Vice Chairman of International Society of Cryosurgery) gave a lecture in the 5^th Academy Conference for Asian Society of Cryosurgery (ASC) in Malaysia.

On Jan. 6, 2019, Dr. Niu was invited to attend and give a lecture in the 4^th China Conference on Microwave Ablation (CCMA2019) and 2^nd SIO Annual Symposium on Tumor Ablation in Nanjing, China.

Review of consultation

FUDA doctor is sharing anti-cancer knowledge with audience during consultation in Hong Kong office of Fuda Cancer Hospital.

FUDA doctor is invited to give a cancer-related speech in Hong Kong community.

Q&A session after lecture in Hong Kong office